SCHEMBL2434550

SCHEMBL2434550

Cn1c(=O)cc(O)c2cc(-c3ccccc3)nnc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.45
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 2/20 0.40
COMT P21964 1/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
PKM P14618 1/20 0.38
MAOB P27338 1/20 0.38
AGTR1 P30556 1/20 0.38
RAB9A P51151 1/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 2/20 0.38
THRB P10828 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
BACE1 P56817 3/20 0.37
MEN1 O00255 1/20 0.37
CASP1 P29466 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2436105 0.71 EGLN1 (0.52) ALDH1A1HSD17B10MAPTSMN1; SMN2NPC1
SCHEMBL336460 0.69 EGLN1 (0.55)
SCHEMBL5871967 0.68 FEN1 (0.54) ALDH1A1HSD17B10COMTMAPTHPGD
SCHEMBL11294253 0.68 GLO1 (0.52) ALDH1A1HSD17B10COMTSMN1; SMN2KDM4E
SCHEMBL835056 0.66 KDM4E (0.65) ALDH1A1HSD17B10MAPTSMN1; SMN2HPGD
SCHEMBL11591420 0.66 KDM4E (0.46) ADORA1ALDH1A1HSD17B10MAPTNPC1
SCHEMBL4493177 0.66 BACE1 (0.63) ADORA1ALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL8767485 0.64 ALDH1A1 (0.56) ADORA1ALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL2439702 0.64 HSD17B10 (0.38) ALDH1A1HSD17B10COMTMAPTHPGD
SCHEMBL11589606 0.63 ALDH1A1 (0.54) ADORA1ALDH1A1HSD17B10MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142509-B1 QUINOLONES AND AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE AMGEN INC (US) 2013-12-04 EP disclosed
US-8349868-B2 Azaquinolones that inhibit prolyl hydroxylase AMGEN INC. (US) 2013-01-08 US disclosed
US-8048894-B2 Quinolones and azaquinolones that inhibit prolyl hydroxylase AMGEN INC. (US) 2011-11-01 US disclosed
US-20110224248-A1 AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE AMGEN INC. (US) 2011-09-15 US disclosed
EP-2142509-A2 QUINOLONES AND AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE Amgen, Inc (US) 2010-01-13 EP disclosed
US-20090156605-A1 Quinolones and azaquinolones that inhbit prolyl hydroxylase AMGEN INC. (US) 2009-06-18 US disclosed
WO-2008130600-A2 QUINOLONES AND AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE AMGEN INC. (US) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156605-A1 Quinolones and azaquinolones that inhbit prolyl hydroxylase EGLN3, HIF1AN, EGLN2 ADORA1 3910/4885ALDH1A1 191/4885HSD17B10 692/4885
US-20110224248-A1 AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE HIF1AN, EGLN3, EGLN2 ADORA1 3808/4885ALDH1A1 145/4885HSD17B10 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.